M&A Deal · 16 Dec 2025
Vireo
Acquirer
PharmaCann
Target
$49m
Deal value
All-Stock + Liabilities
Type
US
Region
Announced
Status
Announced
Completed
$49m all-stock plus assumption of certain liabilities. PharmaCann Colorado assets.
More deals by Vireo
Vireo → FLUENT All-Stock + Debt
All-Stock Acquisition + $30m Debt-for-Stock · 2026
Vireo → Eaze $47m
All-Stock Acquisition · 2025
Vireo → Schwazze $62m
Convertible Notes · 2025
Vireo → Proper Brands / Deep Roots / WholesomeCo / The Flowery ~$397m
Multi-Acquisition (All-Stock) · 2024